Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.14
- Piotroski Score 5.00
- Grade Buy
- Symbol (OSIS)
- Company OSI Systems, Inc.
- Price $167.04
- Changes Percentage (1.03%)
- Change $1.71
- Day Low $166.23
- Day High $168.68
- Year High $168.68
OSI Systems, Inc. designs and manufactures electronic systems and components worldwide. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation detection, and explosive and narcotics trace detection systems under the Rapiscan Systems, AS&E, and Gatekeeper names. It also provides site design, installation, training, and technical support services; and security screening solutions under the S2 name. The Healthcare segment offers patient monitoring and diagnostic cardiology systems, and related supplies and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment provides optoelectronic devices under the OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. It also offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC names; and LCD displays for medical, industrial, and consumer electronics applications, as well as flex circuits for OEM customers. This segment offers laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan and Autosense names; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode name. The company was incorporated in 1987 and is headquartered in Hawthorne, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 01/23/2025
- Fiscal Year End N/A
- Average Stock Price Target $175.00
- High Stock Price Target $178.00
- Low Stock Price Target $175.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $7.28
- Trailing P/E Ratio 19.04
- Forward P/E Ratio 19.04
- P/E Growth 19.04
- Net Income $128.15 M
Income Statement
Quarterly
Annual
Latest News of OSIS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Candace Cameron Bure gets emotional in teary-eyed response to Dave Coulier's cancer diagnosis: 'Been praying'
Candace Cameron Bure shared her support for her "Full House" co-star Dave Coulier after his cancer diagnosis, emphasizing faith and prayer. She also discussed her journey with Christianity and the imp...
By Fox News | 19 hours ago -
Osisko Gold Royalties Ltd (OR): A Top Silver Mining Stock to Buy Right Now
A list of the best silver mining stocks includes Osisko Gold Royalties Ltd. Silver's value rose due to high industrial demand, especially from EV manufacturers, solar power, and electronics. Geopoliti...
By Yahoo! Finance | 1 day ago -
John Stamos wears bald cap in 'solidarity' with Dave Coulier after cancer diagnosis
John Stamos expressed love and support for his former co-star Dave Coulier, who was diagnosed with stage 3 cancer. Coulier shared his battle with Non-Hodgkin lymphoma, undergoing chemotherapy with hop...
By USA Today | 3 days ago
